Intercure (XTAE:INCR) 1-Year Share Buyback Ratio : -3.50% (As of Dec. 2024 )

View and export this data going back to 2007. Start your Free Trial

What is Intercure 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Intercure's current 1-Year Share Buyback Ratio was -3.50%.

XTAE:INCR's 1-Year Share Buyback Ratio is ranked better than
62.78% of 540 companies
in the Drug Manufacturers industry
Industry Median: -1.7 vs XTAE:INCR: -3.50

Competitive Comparison of Intercure's 1-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intercure's 1-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Intercure's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Intercure 1-Year Share Buyback Ratio Calculation

Intercure's 1-Year Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2023 )	-	Shares Outstanding (EOP) (Dec. 2024 ))	/	Shares Outstanding (EOP) (Dec. 2023 )
	=	(45.573	-	47.163)	/	45.573
	=	-3.5%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intercure (XTAE:INCR) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Intercure 1-Year Share Buyback Ratio Related Terms

Intercure Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (XTAE:INCR) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

INCR:USA

Address

85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670

Website

https://www.intercure.co

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.